NCT05612958View on ClinicalTrials.gov

Efficacy and Safety of a 'Graft/Prosthesis, Biomaterial (DKM410)' in the Treatment of Both Nasolabial Folds

NACompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

March 23, 2021

Primary Completion Date

January 14, 2022

Study Completion Date

June 28, 2022

Conditions
Nasolabial Folds
Interventions
DEVICE

DKM-410

Injection up to 2.0ml

DEVICE

Juvederm ULTRA PLUS XC 1.0ml

Injection up to 2.0ml

Trial Locations (1)

Unknown

Chung-Ang University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Dongkook Pharmaceutical Co., Ltd.

INDUSTRY

NCT05612958 - Efficacy and Safety of a 'Graft/Prosthesis, Biomaterial (DKM410)' in the Treatment of Both Nasolabial Folds | Biotech Hunter | Biotech Hunter